Drug profile · INN
eravacycline
XERAVA
eravacycline (XERAVA) is a bacterial 70s ribosome inhibitor.
EMA: approved Antiinfectives for systemic use (J01) J01AA13
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — eravacycline
- Class
- Antiinfectives for systemic use (J01)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
eravacycline (XERAVA) is a bacterial 70s ribosome inhibitor.
Key facts
INN eravacycline
Brand XERAVA
Mechanism Bacterial 70S ribosome inhibitor
Target Bacterial 70S ribosome
Therapeutic class Antiinfectives for systemic use (J01)
ATC code J01AA13
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is eravacycline?
eravacycline (XERAVA) is a bacterial 70s ribosome inhibitor.
What is the brand name for eravacycline?
XERAVA is a marketed brand name for eravacycline. Check FDA Drugs@FDA for the current US label holder and prescribing information.